Additive effects of trastuzumab and genistein on human breast cancer cells

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Anti-Cancer Drugs

• Publication date

  2011-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/CAD.0b013e3283427bb5PMID 21160418
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HER-2 signaling and inhibition in breast cancer.

  2009cited by this paper
• Multiple mechanisms of soy isoflavones against oxidative stress-induced endothelium injury.

  2009cited by this paper
• The role of trastuzumab in the management of HER2-positive metastatic breast cancer: an updated review

  2009cited by this paper
• Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells

  2009cited by this paper
• The effect of genistein aglycone on cancer and cancer risk: a review of in vitro, preclinical, and clinical studies.

  2009cited by this paper
• Perspectives on the soy-breast cancer relation.

  2009cited by this paper
• Genistein inhibits differentiation of primary human adipocytes.

  2009cited by this paper
• Cell lines as candidate reference materials for quality control of ERBB2 amplification and expression assays in breast cancer.

  2009cited by this paper
• Trastuzumab reverses letrozole resistance and amplifies the sensitivity of breast cancer cells to estrogen.

  2009cited by this paper
• Her-2/neu amplification and breast cancer survival: results from the Shanghai breast cancer study.

  2008cited by this paper
• Involvement of the estrogen receptor β in genistein-induced expression of p21[waf1/cip1] in PC-3 prostate cancer cells

  2008cited by this paper
• Phytoestrogen-mediated inhibition of proliferation of the human T47D breast cancer cells depends on the ERalpha/ERbeta ratio.

  2008cited by this paper
• Estrogen Receptors alpha and beta as determinants of gene expression: influence of ligand, dose, and chromatin binding.

  2008cited by this paper
• Plasma isoflavone level and subsequent risk of breast cancer among Japanese women: a nested case-control study from the Japan Public Health Center-based prospective study group.

  2008cited by this paper
• Involvement of the estrogen receptor beta in genistein-induced expression of p21(waf1/cip1) in PC-3 prostate cancer cells.

  2008cited by this paper
• Estrogen Receptors (cid:1) and (cid:2) as Determinants of Gene Expression: Influence of Ligand, Dose, and Chromatin Binding

  2008cited by this paper
• The role of hormonal therapy in the management of hormonal-receptor-positive breast cancer with co-expression of HER2

  2008cited by this paper
• Multi-targeted therapy of cancer by genistein.

  2008cited by this paper
• Genistein affects HER2 protein concentration, activation, and promoter regulation in BT-474 human breast cancer cells

  2007cited by this paper
• Phytoestrogens activate estrogen receptor beta1 and estrogenic responses in human breast and bone cancer cell lines.

  2007cited by this paper
• Effects of exon-deleted estrogen receptor β transcript variants on growth, apoptosis and gene expression of human breast cancer cell lines

  2007cited by this paper
• Expression of wild‐type estrogen receptor β protein in human breast cancer: Specific correlation with HER2/neu overexpression

  2006cited by this paper
• Comprehensive copy number profiles of breast cancer cell model genomes

  2006cited by this paper
• Co-expression of steroid and HER2 receptors in breast carcinomas in a large (4,493 cases) population-based Polish study

  2005cited by this paper
• Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest.

  2004cited by this paper
• Effects of Herceptin treatment on global gene expression patterns in HER2-amplified and nonamplified breast cancer cell lines

  2004cited by this paper
• Loss of ERbeta expression as a common step in estrogen-dependent tumor progression.

  2004cited by this paper
• Reduced expression of oestrogen receptor β in invasive breast cancer and its re‐expression using DNA methyl transferase inhibitors in a cell line model

  2003cited by this paper
• Lack of significant genotoxicity of purified soy isoflavones (genistein, daidzein, and glycitein) in 20 patients with prostate cancer.

  2003cited by this paper
• Quantitative Real-Time PCR Method for Detection of B-Lymphocyte Monoclonality by Comparison of κ and λ Immunoglobulin Light Chain Expression

  2003cited by this paper
• Quantitative real-time PCR method for detection of B-lymphocyte monoclonality by comparison of kappa and lambda immunoglobulin light chain expression.

  2003cited by this paper
• Phytoestrogen concentrations in serum from Japanese men and women over forty years of age.

  2002cited by this paper
• Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men.

  2002cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Interactions of dietary estrogens with human estrogen receptors and the effect on estrogen receptor-estrogen response element complex formation.

  2000cited by this paper
• Induction of apoptosis and inhibition of c-erbB-2 in MDA-MB-435 cells by genistein.

  1999cited by this paper
• Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein

  1999cited by this paper
• Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer.

  1999cited by this paper
• Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta.

  1998cited by this paper
• Regulation of c-fos transcription by chemopreventive isoflavonoids and lignans in MDA-MB-468 breast cancer cells.

  1998cited by this paper
• A novel isoform of rat estrogen receptor beta with 18 amino acid insertion in the ligand binding domain as a putative dominant negative regular of estrogen action.

  1998cited by this paper
• Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans.

  1998cited by this paper
• Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors a and b

  1997cited by this paper
• Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta.

  1997cited by this paper
• Cloning of a novel receptor expressed in rat prostate and ovary.

  1996cited by this paper
• Dietary phyto-oestrogens and the menopause in Japan.

  1992cited by this paper
• Use and specificity of genistein as inhibitor of protein-tyrosine kinases.

  1991cited by this paper
• Genistein, a specific inhibitor of tyrosine-specific protein kinases.

  1987cited by this paper
• A specific inhibitor for tyrosine protein kinase from Pseudomonas.

  1986cited by this paper
• Protein-tyrosine kinases.

  1985cited by this paper
• Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.

  1984cited by this paper
• Phytoestrogen interaction with estrogen receptors in human breast cancer cells.

  1978cited by this paper

• Genistein as a Chemo-modulatory Agent: Exploring its Potential in Chemosensitization and Combinatorial Therapeutic Strategies for Cancer Treatment.

  2025cites this paper
• Genistein, a Potential Phytochemical against Breast Cancer Treatment-Insight into the Molecular Mechanisms

  2022influential citation
• Combinational Therapy Using Chemotherapeutic Agents and Dietary Bioactive Compounds

  2021cites this paper
• Effects and mechanisms of dietary bioactive compounds on breast cancer prevention.

  2021cites this paper
• Osteopontin and breast cancer metastasis: possible role of genistein on the regulation of osteopontin

  2021cites this paper
• Genistein Mediated Molecular Pharmacology, Cell-Specific Anti-Breast Cancer Mechanism with Synergistic Effect and in silico Safety Measurement

  2021influential citation
• Prenylated flavonoids in foods and their applications on cancer prevention

  2021cites this paper
• Supplementing Genistein for Breeder Hens Alters the Fatty Acid Metabolism and Growth Performance of Offsprings by Epigenetic Modification

  2019cites this paper
• The combinatory effects of natural products and chemotherapy drugs and their mechanisms in breast cancer treatment

  2019cites this paper
• Dietary isoflavones, the modulator of breast carcinogenesis: Current landscape and future perspectives

  2018cites this paper
• Phytochemicals: Current strategies for treating breast cancer.

  2018cites this paper
• 1H Nuclear Magnetic Resonance Based Metabolomics Approach Reveals the Metabolic Mechanism of (-)-5-Hydroxy-equol against Hepatocellular Carcinoma Cells in Vitro.

  2018cites this paper
• Prevention of Breast Cancer by Natural Phytochemicals: Focusing on Molecular Targets and Combinational Strategy

  2018cites this paper
• The Comparison of MTT and CVS Assays for the Assessment of Anticancer Agent Interactions

  2016cites this paper
• Soy Isoflavones and Breast Cancer Cell Lines: Molecular Mechanisms and Future Perspectives

  2015cites this paper
• Phytoestrogens Modulate Breast Cancer Resistance Protein Expression and Function at the Blood-Cerebrospinal Fluid Barrier.

  2015cites this paper
• Sustained proliferation in cancer: Mechanisms and novel therapeutic targets.

  2015cites this paper
• Natural compounds: Role in reversal of epigenetic changes

  2015cites this paper
• Phytochemicals for breast cancer therapy: current status and future implications.

  2015cites this paper
• Downregulation of clusterin mediates sensitivity to protein kinase inhibitors in breast cancer cells

  2015cites this paper
• Genistein exhibits anti-cancer effects via down-regulating FoxM1 in H446 small-cell lung cancer cells

  2014cites this paper
• Genistein enhances the effect of cisplatin on the inhibition of non-small cell lung cancer A549 cell growth in vitro and in vivo

  2014cites this paper
• Equol induces apoptosis in human hepatocellular carcinoma SMMC-7721 cells through the intrinsic pathway and the endoplasmic reticulum stress pathway

  2014cites this paper
• Estrogen receptor β agonists affect growth and gene expression of human breast cancer cell lines.

  2013cites this paper
• Endocrine Disruptors and Breast Cancer Risk - Time to Consider the Environment

  2012cites this paper
• Estrogen receptor-beta and breast cancer: translating biology into clinical practice.

  2012cites this paper
• Differential Influence of Dietary Soy Intake on the Risk of Breast Cancer Recurrence Related to HER2 Status

  2012cites this paper
• Genistein enhances the effect of trichostatin A on inhibition of A549 cell growth by increasing expression of TNF receptor-1.

  2012cites this paper
• Profiling flavonoid cytotoxicity in human breast cancer cell lines

  2012cites this paper
• Soybean: Food or Remedy?

  2011cites this paper
• Epigenetic diet: impact on the epigenome and cancer.

  2011cites this paper
• Genistein: The future of prevention and treatment of breast cancer?

  2011cites this paper